Moreover, expression of MCL-1 and BCL-XL are both tightly regulated by IL-6 [32] The ability of ectopic expression of these proteins to protect MM cells, albeit partially, from ATR inhibitor-mediated cell death argues that down-regulation of these proteins plays a significant role in anti-MM actions. The gene discussed is MCL1; the disease is Miyoshi myopathy.